Abstract
Adrenal cortical carcinomas (ACC) are rare, typically aggressive malignant neoplasms with a reported incidence of 1–2 cases per 1 million population and account for 0.05–0.2 % of all malignancies. The majority of these tumors are functional with approximately 60 % of patients experiencing endocrine symptomatology typically characterized by Cushing’s syndrome (40 %) or a mixed hormonal picture of Cushing syndrome seen in association with virilization. Rarely, patients present with a pure hormonal syndrome of feminization or hyperaldosteronism, 6 and 2.5 %, respectively. We report a case of a 76-year-old woman presenting with recently diagnosed hypertension secondary to primary hyperaldosteronism. The patient underwent laparoscopic converted to an open adrenalectomy and a diagnosis of adrenocortical carcinoma (aldosteronoma clinical) was rendered. This case and review of the literature highlight that while rare, aldosterone-secreting adrenal cortical carcinomas may occur. In this case report, we discuss the clinical presentation, pathologic findings, and review the literature for adrenal cortical carcinomas and aldosterone-secreting adrenal cortical carcinomas.
Similar content being viewed by others
References
Allolio B, Fassnacht M. (2009) Clinical Review: Adrenocortical Carcinoma: Clinical Update. J. Clin. Endocrinol. Metab 91(6):2027–2037.
Mills S. (2010) Diagnostic Surgical Pathology, 5th Edition. Lippincott Williams and Wilkins, Baltimore
Ng L, Libertino J. (2003) Adrenocortical Carcinoma: Diagnosis, Evaluation and Treatment. J Urol 169:5–11.
Soon PS, McDonald KL, Robinson BG, Sidhu SB. (2008) Molecular Markers and the Pathogenesis of Adrenocortical Cancer. Oncologist 13:1548–561.
Veytsman, Nieman L, Fojo T (2009) Management of Endocrine Manifestations and the Use of Mitotane as a Chemotherapeutic Agent for Adrenocortical Carcinoma. J Clin Oncol 27:4619–4629.
Balasubramaniam S, Fojo T. (2010) Practical Considerations in the Evaluation and Management of Adrenocortical Cancer. Semin Oncol 37(6):619–626.
Weiss LM (1984) Comparative histopathologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163–9
Weiss LM, Medeiros LJ, Vickery AL Jr (1989) Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202–6
Aubert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M, Leteurtre E. (2002) Weiss System Revisited: A Clinicopathologic and Immunohistochemical Study of 49 Adrenocortical Tumors. Am J Surg Pathol 26(12):1612–1619
Hough AJ, Hollifield JW, Page DL, Hartmann WH (1979) Prognostic factors in adrenal cortical tumors: a mathematical analysis of clinical and morpholgic data. Am J Clin Path 72:390–9
Van Slooten H, Schaberg A, Smeenk D, Moolenaar AJ (1985) Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 55:766–73.
Sasano H, Suzuki T, Moriya T (2006) Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr Pathol 17(4):345–354
Seccia TM, Fassina A, Nussdorfer GG, Pessina AC, Rossi GP. (2005) Aldosterone-producing adrenocortical carcinoma: an unusually cause of Conn’s syndrome with an ominous clinical course. Endocrine-Related Cancer 12:14–159
Hsieh M, Chen JH, Lin LW (2011) Myxoid Adrenal Cortical Carcinoma Presenting as Primary Hyperaldosteonism: Case Report and Review of the Literature. Int J Surg 19(6):803–7
Mussig K, Wehrmann M, Horger M, Teichmann R, Maser-Gluth C, Häring HU, Overkamp D. (2005) Steroid Profile in an Adrenocortical Carcinoma Producing Aldosterone. Exp Clin Endocrinol Diabetes 113:236–240
Abma EM, Kluin PM, Dullaart RP.(2008) Malignant aldosterone-producing adrenal tumor: reoccurrence with glucocorticoid excess without hyperaldosteronism. 66(6): 252–255.
Sun X, Ayala A, Castro CY (2005) Adrenocortical Carcinoma with Concomitant Myelolipoma in a Patient with Hyperaldosteronism. Arch Pathol Lab Med 129:e144–e147.
Song MS, Seo SW, Bae SB, Kim YJ, Kim SJ. (2012) Aldosterone-producing adrenocortical carcinoma without hypertension. Korean J Intern Med. 27(2):221–3
Miller BS, Ammori JB, Gauger PG, Broome JT, Hammer GD, Doherty GM (2010) Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma. World J Surg 34:1380–5
Jurowich C, Fassnacht M, Kroiss M, Deutschbein T, Germer CT, Reibetanz J (2013) Is there a role for laparoscopic adrenalectomy in patients with suspected adrenocortical carcinoma? A critical appraisal of the literature. Horm Metab Res 45:130–136.
Gonzalez R, Shapiro S, Sarlis N, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE (2005) Laparoscopic resection of adrenal cortical carcinoma: A cautionary note. Surgery 138(6):1078–1086
Brix D, Allolio B, Fenske W, Agha A, Dralle H, Jurowich C, Langer P, Mussack T, Nies C, Riedmiller H, Spahn M, Weismann D, Hahner S, Fassnacht M; German Adrenocortical Carcinoma Registry Group (2010) Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients. Eur Urol 58:609–615.
Fassnacht M, Allolio B. (2009) Clinical Management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 23: 273–289.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Griffin, A.C., Kelz, R. & LiVolsi, V.A. Aldosterone-Secreting Adrenal Cortical Carcinoma. A Case Report and Review of the Literature. Endocr Pathol 25, 344–349 (2014). https://doi.org/10.1007/s12022-014-9307-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-014-9307-x